Metabolic syndrome, a serious condition impacting adults and children in all genders, races and ethnicities, can lead to fatal outcomes if not detected and treated. The key risk factors of metabolic syndrome were identified approximately 250 years ago. However, there still remains much uncertainty regarding the diagnostic criteria.
So how are central laboratories playing a key role in its detection and treatment?
The tests, methodologies and instrumentation being used by central laboratories today have evolved enormously in recent years, enabling metabolic syndrome to be quickly and more easily detected and making treatment and successful management of this condition more attainable
ACM Global’s Clinical Insight white paper explores the history and evolution of metabolic syndrome and discusses the ongoing debate that still exists around the criteria for diagnosing it. In spotlighting some of the current tests, this paper gives healthcare providers and clinical trial sponsors insight into some of the latest tools needed in aiding prevention and treatment of this increasingly common and serious health condition.